SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis
-
- Sergiy Sukhanov
- From the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.)
-
- Yusuke Higashi
- From the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.)
-
- Shaw-Yung Shai
- Heart and Vascular Institute (S.-Y.S., V.D., M.T.), Tulane University School of Medicine, New Orleans, LA
-
- Patricia Snarski
- From the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.)
-
- Svitlana Danchuk
- From the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.)
-
- Veronica D’Ambra
- Heart and Vascular Institute (S.-Y.S., V.D., M.T.), Tulane University School of Medicine, New Orleans, LA
-
- Michael Tabony
- Heart and Vascular Institute (S.-Y.S., V.D., M.T.), Tulane University School of Medicine, New Orleans, LA
-
- T. Cooper Woods
- Department of Physiology (T.C.W.), Tulane University School of Medicine, New Orleans, LA
-
- Xuwei Hou
- From the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.)
-
- Zhaohui Li
- From the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.)
-
- Atsufumi Ozoe
- Graduate School of Agriculture and Life Sciences, University of Tokyo, Bunkyo-ku, Japan (A.O., S.-I.T.)
-
- Bysani Chandrasekar
- From the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.)
-
- Shin-Ichiro Takahashi
- Graduate School of Agriculture and Life Sciences, University of Tokyo, Bunkyo-ku, Japan (A.O., S.-I.T.)
-
- Patrice Delafontaine
- From the University of Missouri-Columbia School of Medicine (S.S., Y.H., P.S., S.D., X.H., Z.L., B.C., P.D.)
書誌事項
- 公開日
- 2018-10
- 資源種別
- journal article
- DOI
-
- 10.1161/atvbaha.118.311134
- 公開者
- Ovid Technologies (Wolters Kluwer Health)
この論文をさがす
説明
<jats:sec> <jats:title>Objective—</jats:title> <jats:p> IGF-1 (insulin-like growth factor 1) is a major autocrine/paracrine growth factor, which promotes cell proliferation, migration, and survival. We have shown previously that IGF-1 reduced atherosclerosis and promoted features of stable atherosclerotic plaque in Apoe <jats:sup>−/</jats:sup> <jats:sup>−</jats:sup> mice—an animal model of atherosclerosis. The aim of this study was to assess effects of smooth muscle cell (SMC) IGF-1 signaling on the atherosclerotic plaque. </jats:p> </jats:sec> <jats:sec> <jats:title>Approach and Results—</jats:title> <jats:p> We generated Apoe <jats:sup>−/−</jats:sup> mice with IGF1R (IGF-1 receptor) deficiency in SMC and fibroblasts (SM22α [smooth muscle protein 22 α]-CreKI/IGF1R-flox mice). IGF1R was decreased in the aorta and adventitia of SM22α-CreKI/IGF1R-flox mice and also in aortic SMC, embryonic, skin, and lung fibroblasts isolated from SM22α-CreKI/IGF1R-flox mice. IGF1R deficiency downregulated collagen mRNA-binding protein LARP6 (La ribonucleoprotein domain family, member 6) and vascular collagen, and mice exhibited growth retardation. The high-fat diet–fed SM22α-CreKI/IGF1R-flox mice had increased atherosclerotic burden and inflammatory responses. α-SMA (α-smooth muscle actin)–positive plaque cells had reduced proliferation and elevated apoptosis. SMC/fibroblast-targeted decline in IGF-1 signaling decreased atherosclerotic plaque SMC, markedly depleted collagen, reduced plaque fibrous cap, and increased plaque necrotic cores. Aortic SMC isolated from SM22α-CreKI/IGF1R-flox mice had decreased cell proliferation, migration, increased sensitivity to apoptosis, and these effects were associated with disruption of IGF-1–induced Akt signaling. </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>IGF-1 signaling in SMC and in fibroblast is a critical determinant of normal vascular wall development and atheroprotection.</jats:p> </jats:sec>
収録刊行物
-
- Arteriosclerosis, Thrombosis, and Vascular Biology
-
Arteriosclerosis, Thrombosis, and Vascular Biology 38 (10), 2306-2317, 2018-10
Ovid Technologies (Wolters Kluwer Health)